We speculate these observations reflect the biological importance of DLC1 tumor suppressor to the cancer process, which probably contributes to its frequent downregulation in cancer, especially lung cancer13, together with the ability of the inhibitors to reactivate DLC1 tumor suppressor protein by complementary, non-overlapping mechanisms. The gene discussed is DLC1; the disease is cancer.